Risk-factor observations and limits in under-eye nodule care

This edited account distinguishes personal experience, laboratory research and clinical studies. Individual suitability requires clinical assessment.

The source lists five features the author noticed among under-eye nodule patients: body composition, botulinum-toxin history, previous surgery or procedures, dryness and immune-related history. These are observations in selected patients, not a validated prediction tool.

The statement that 99% were thin women lacks a denominator of all treated people, a comparison group and a described collection method. The composition of a referral group is different from a body type’s true risk.

Proposed links between toxin, adhesions, hydration, blood flow and nodules also require direct clinical evidence. Autoimmune disease or a previous vaccine reaction alone does not establish an excessively reactive constitution.

These items are retained as examples of history-taking questions. They do not mean absence ensures safety or presence requires avoiding treatment. Material, site, symptoms and individual circumstances matter.